Avanos Medical Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y

Key Takeaways AVNS beat Q4 EPS and revenue estimates, but shares fell nearly 10% yesterday.Avanos Medical's SNS sales rose 8.7%, led by enteral feeding and neonate solutions growth.AVNS guides 2026 sales of $700-$720M and EPS of 90 cents to $1.10 amid tariff headwinds.Avanos Medical, Inc. (AVNS) reported fourth-quarter 2025 adjusted earnings per share (EPS) from continuing operations of 29 cents, down 32.6% year over year. However, the bottom line beat the Zacks Consensus Estimate of 24 cents by 20.8%.GAAP ...